TATA健康(01255.HK)接获额外复牌指引 继续停牌

Group 1 - TATA Health (01255.HK) received a letter from the Stock Exchange on September 4, 2025, regarding the resumption of trading [1] - The Stock Exchange requires the company to rectify the issues that led to its suspension and to fully comply with listing rules to regain trading approval [1] - The company is primarily responsible for formulating its action plan for resumption, and the Stock Exchange may modify resumption guidelines or provide further instructions at an appropriate time [1]